Article Text
PDFResearch ethics
Paper
Improving access to medicines: empowering patients in the quest to improve treatment for rare lethal diseases
Statistics from Altmetric.com
Footnotes
Funding The Wellcome Trust.
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Motor neuron disease
- Using telehealth in motor neuron disease to increase access to specialist multidisciplinary care: a UK - based pilot and feasibility study
- Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
- Experiences and reflections of patients with motor neuron disease on breaking the news in a two - tiered appointment: a qualitative study
- Epidemiology of ALS in Korea using nationwide big data
- An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease
- Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population - based cohort study
- Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS - R
- Prevalence and factors associated with advanced care directives in a motor neuron disease multidisciplinary clinic in Australia
- Imaging muscle as a potential biomarker of denervation in motor neuron disease